<?xml version="1.0" encoding="UTF-8"?>


<article dtd-version="1.0" article-type="research-article">
  <front>
      <journal-meta>
         <journal-id xmlns:xlink="http://www.w3.org/1999/xlink" journal-id-type="jstor">intejhealeconman</journal-id>
         <journal-id xmlns:xlink="http://www.w3.org/1999/xlink" journal-id-type="jstor">j50020182</journal-id>
         <journal-title-group xmlns:xlink="http://www.w3.org/1999/xlink">
            <journal-title>International Journal of Health Economics and Management</journal-title>
         </journal-title-group>
      
         <publisher>
            <publisher-name>Springer</publisher-name>
         </publisher>
         <issn xmlns:xlink="http://www.w3.org/1999/xlink" pub-type="ppub">21999023</issn>
         <issn xmlns:xlink="http://www.w3.org/1999/xlink" pub-type="epub">21999031</issn>
         <custom-meta-group xmlns:xlink="http://www.w3.org/1999/xlink"/>
      </journal-meta>
      <article-meta xmlns:xlink="http://www.w3.org/1999/xlink">
         <volume xmlns:mml="http://www.w3.org/1998/Math/MathML"
                 xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">16</volume>
         <issue xmlns:mml="http://www.w3.org/1998/Math/MathML"
                xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">4</issue>
         <issue-id>i40228034</issue-id>
         <article-id pub-id-type="doi">10.2307/45271473</article-id>
         <article-categories>
            <subj-group>
               <subject>RESEARCH ARTICLE</subject>
            </subj-group>
         </article-categories>
         <title-group>
            <article-title>Is medicines parallel trade 'regulatory arbitrage'?</article-title>
         </title-group>
         <contrib-group>
            <contrib>
               <string-name>
                  <given-names>Joan</given-names>
                  <surname>Costa-Font</surname>
               </string-name>
            </contrib>
         </contrib-group>
         <pub-date pub-type="ppub">
            <day>1</day>
            <month>12</month>
            <year>2016</year>
         </pub-date>
         <fpage>321</fpage>
         <lpage>336</lpage>
      
      
      
      
      
      
      
         <self-uri xlink:href="https://www.jstor.org/stable/45271473"/>
      
      
         <abstract>
            <p>Parallel trade (PT) is a phenomenon that takes place at the distribution level, when a patented product is diverted from the official distribution chain to another one where it competes as a parallel distributor. Although some research regards PT in Europe as a 'common' form of arbitrage, there are reasons to believe that it is a type of 'regulatory arbitrage' that does not necessarily produce equivalent welfare effects. We draw upon a unique dataset that contains source country records of parallel imported medicine sales to the Netherlands for one therapeutic group (statins), that accounts for 5 % of the market at the time of study and it faced no generic competition. We estimate precise differences in prices and statutory distribution margins for each source country/product and, examine whether they drive parallel import flows using a gravity specification and an instrumental variable strategy. Our findings reveal that parallel imports are driven by cross-country differences in statutory distribution margins in addition to price differences, consistently with the hypothesis of PT being a type of 'regulatory arbitrage'.</p>
         </abstract>
         <custom-meta-group>
            <custom-meta>
               <meta-name>lang</meta-name>
               <meta-value>eng</meta-value>
            </custom-meta>
         </custom-meta-group>
      </article-meta>
  </front>
  <back>
    
      <fn-group xmlns:xlink="http://www.w3.org/1999/xlink">
        <title>[Footnotes]</title>
        <fn id="d471e187a1310">
            <label>2</label>
          
            <p>
               <mixed-citation id="d471e194" publication-type="other">
Anderson and Ginsburgh 1999</mixed-citation>
            </p>
        </fn>
      </fn-group>
    
    
      <ref-list>
        <title>References</title>
        <ref id="d471e210a1310">
          
            <mixed-citation id="d471e214" publication-type="other">
Anderson, S. P., &amp; Ginsburgh, V. A. (1999). International pricing with costly consumer arbitrage. Review of
International Economies, 7(1), 126-139.</mixed-citation>
        </ref>
        <ref id="d471e224a1310">
          
            <mixed-citation id="d471e228" publication-type="other">
Angrist, J. D., &amp; Krueger, A. B. (2001). Instrumental variable and the search for identification: From supply
and demand to natural experiments. Journal of Economic Perspectives, 15(4), 69-85.</mixed-citation>
        </ref>
        <ref id="d471e238a1310">
          
            <mixed-citation id="d471e242" publication-type="other">
Bougheas, S., Demetriades, P. O., &amp; Morgenroth, E. L. W. (1999). Infrastructure, transport costs and trade.
Journal of International Economics, 47, 169-189.</mixed-citation>
        </ref>
        <ref id="d471e252a1310">
          
            <mixed-citation id="d471e256" publication-type="other">
Costa-Font, J., McGuire, A., &amp; Varol, N. (2014). Price regulation and relative delays in generic drug adoption.
Journal of Health Economics, 38, 1-9.</mixed-citation>
        </ref>
        <ref id="d471e267a1310">
          
            <mixed-citation id="d471e271" publication-type="other">
Costa-Font, J., McGuire, A., &amp; Varol, N. (2015). Regulation effects on the adoption of new medicines. Empir-
ical Economics, 49(3), 1101-1121.</mixed-citation>
        </ref>
        <ref id="d471e281a1310">
          
            <mixed-citation id="d471e285" publication-type="other">
Egger, P. (2000). A note on the proper econometric specification of the gravity equation. Economics Letters,
66(1), 25-31.</mixed-citation>
        </ref>
        <ref id="d471e295a1310">
          
            <mixed-citation id="d471e299" publication-type="other">
Egger, P. (2002). An econometric view on estimation of gravity models and the calculation of tradepotential.
World Economy, 25(2), 297-312.</mixed-citation>
        </ref>
        <ref id="d471e309a1310">
          
            <mixed-citation id="d471e313" publication-type="other">
European Association of Pharmaceutical Wholesalers. (2005). Annual Report 2004/5. Brussels.</mixed-citation>
        </ref>
        <ref id="d471e320a1310">
          
            <mixed-citation id="d471e324" publication-type="other">
Frank R.G., &amp; SalkeverD.S. (1991). Pricing, Patent Loss and the Market for Pharmaceuticals. NBER Working
Paper #3803.</mixed-citation>
        </ref>
        <ref id="d471e334a1310">
          
            <mixed-citation id="d471e338" publication-type="other">
Ganslandt, M., &amp; Maskus, K. E. (2004). Parallel Imports and the pricing of pharmaceutical products: Evidence
form the European Union. Journal of Health Economics, 23(5), 1035-1057.</mixed-citation>
        </ref>
        <ref id="d471e349a1310">
          
            <mixed-citation id="d471e353" publication-type="other">
Glink, R., &amp; Rose, A. K. (2002). Does a currency union affect trade? The time series evidence. European
Economic Review, 46, 1125-1151.</mixed-citation>
        </ref>
        <ref id="d471e363a1310">
          
            <mixed-citation id="d471e367" publication-type="other">
Grabowski, H., &amp; Vernon, J. (1992). Brand loyalty; entry, and price competition in pharmaceuticals after the
1984 Drug Act. Journal of Law ad Economics, 35, 331-350.</mixed-citation>
        </ref>
        <ref id="d471e377a1310">
          
            <mixed-citation id="d471e381" publication-type="other">
Grossman, G., &amp; Lai, E.L. (2006). Parallel Imports and Price Controls. NBER Working Paper No. W 12423</mixed-citation>
        </ref>
        <ref id="d471e388a1310">
          
            <mixed-citation id="d471e392" publication-type="other">
IMS. (2004). International Medical Statistics Dataset. IMS Health, http://www.imshealth.com/.</mixed-citation>
        </ref>
        <ref id="d471e399a1310">
          
            <mixed-citation id="d471e403" publication-type="other">
Jelovac, I., &amp; Borodoy, C. (2005). Pricing and welfare implications of parallel imports in the pharamaceutical
industry. International Journal of Health Care Finance and Economics, 5, 5-21.</mixed-citation>
        </ref>
        <ref id="d471e413a1310">
          
            <mixed-citation id="d471e417" publication-type="other">
Kanavos, P., &amp; Costa-Font, J. (2005). Pharmaceutical parallel trade m Europe: Impact on stakeholders and
competition effects. Economic Policy, 20(44), 753-798.</mixed-citation>
        </ref>
        <ref id="d471e428a1310">
          
            <mixed-citation id="d471e432" publication-type="other">
Kanavos, P., Costa-Font, J., &amp; Seeley, E. (2008). Competition in off-patent drug markets: Issues, regulation
and evidence. Economic Policy, 23(55), 499-544.</mixed-citation>
        </ref>
        <ref id="d471e442a1310">
          
            <mixed-citation id="d471e446" publication-type="other">
Mauleg, D. A., &amp; Schwartz, M. (1994). Parallel imports, demand dispersion and international price discrimi-
nation. Journal of International Economics, 37, 167.</mixed-citation>
        </ref>
        <ref id="d471e456a1310">
          
            <mixed-citation id="d471e460" publication-type="other">
Paterson, I., Fink, M., Ogus, A. (2003). Economic impact of regulation in the field of liberal professions in
different Member States. Vienna: Study for the European Commission, DG Competition, Institute for
Advanced Studies.</mixed-citation>
        </ref>
        <ref id="d471e473a1310">
          
            <mixed-citation id="d471e477" publication-type="other">
Pecorino, P. (2002). Should the US allow prescription drug Reimports from Canada? Journal of Health
Economics, 27(4), 699-708.</mixed-citation>
        </ref>
        <ref id="d471e487a1310">
          
            <mixed-citation id="d471e491" publication-type="other">
Richardson, M. (2002). An elementary proposition concerning parallel imports. Journal of International
Economics, 56, 233-245.</mixed-citation>
        </ref>
        <ref id="d471e501a1310">
          
            <mixed-citation id="d471e505" publication-type="other">
Wooldridge, J. M. (2010). Econometric analysis of cross section and panel data. MIT Press.</mixed-citation>
        </ref>
      </ref-list>
    
  </back>
</article>


